2 results
Approved WMOCompleted
The objective of this study is to assess the feasibility and initial safety and performance of the TRVD* System when used for renal venous decongestions in patients with acute decompensated heart failure.
Approved WMOCompleted
Primary:* To determine the efficacy of PSI-7977 in combination with RBV administered for 12 weeks compared with PEG/RBV administered for 24 weeks in treatment-naïve patients with HCV genotype 2 or 3 as assessed by the rate of SVR12 (HCV RNA of…